NEW YORK STOCK EXCHANGE, INC. · GMED
0.00% · $0.0000 · Vol Not reported
Market closed · last close shown
Globus Medical Inc

Globus Medical Inc

Health Care
$74.41
Card
Relationship Map

Follow $GMED

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $GMED by email

Veridion Score

BETAHIGH CONF · 6 of 6 factors measuredMethodology

snapshot unavailable for GMED. Cause unavailable.

GMED
Globus Medical Inc
Stale score · Wed Sep 30 · completed session · 39h old · Scheduled each trading day · Pre-market · regular session opens 9:30 ET
Highest qualified

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

75/ 100
Veridion Score
Highest qualified · HIGH confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: HIGH · 6 of 6 factors measured · Stale score · Wed Sep 30 · completed session · 39h old · Scheduled each trading day · Pre-market · regular session opens 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is GMED moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading GMED catalysts
About Globus Medical Inc
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed since
2012
Employees
6K
Country
US

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$74.41
Last session
Day high
$74.41
Last session
Day low
$74.41
Last session
Previous close
$74.41
52W high
$96.82
-23.15% from high
52W low
$56.57
44% of range
Market cap
$10B
P/E
18.78×
EPS
$3.91
Beta
0.02
Shares out
134.3M
Avg volume
1.4M
VWAP
$74.41
Last session
Price history computed in-house
1W
-0.15%
1M
-7.75%
3M
-7.13%
1Y
+28.16%
YTD
-14.77%
SMA 50 $79.55 · below
SMA 200 $84.69 · below
52W position 44%

GMED overview

Loading financial statements
Loading GMED Form 4 filings
Public disclosures

Congress activity in GMED

Federal contracts

GMED contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for GMED in this window.
Lobbying spend

GMED lobbying filings, year to date.

Registered lobbying filings matched to Globus Medical Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for GMED in this window.
Loading news for GMED
Analyst ratings
Sovereign unlock shows live analyst consensus for GMED.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.